Protea is a leader in the emerging field of Bioanalytics. The company develops new technology for the identification, characterization, and quantitation of biologically-important molecules for basic research, pharmaceutical development, and diagnostic applications.
Bioanalytics is the direct identification and characterization of the products of all living cells, including proteins, lipids, metabolites and nucleic acids. Bioanalytics is emerging as a crucial area, where new technology is needed to support the future of medical research, and virtually every other field of life science research.
We develop new bioanalytical methods that enable the direct analysis of proteins and other biomolecules, and apply our capabilities to support your laboratory's research objectives.
No reviews to display
17 Nov 2014
01 Oct 2014
03 Jun 2014
Protea Enters Into Collaborative Research Agreement with the Memorial Sloan-Kettering Cancer Center and the Dana-Farber Cancer Institute
02 May 2014
31 Jan 2014
Single Bead Peptide Microarrays Characterized by Laser Ablation Electrospray Ionization Mass Spectrometry Imaging (LAESI-MSI)Protea Biosciences Group, Inc
04 Sep 2014
High Throughput Spatially Resolved Peptide Identification using Hydrogel Digestion and Electro-ElutionProtea Biosciences Group, Inc
02 Sep 2014
Increased Sensitivity in LAESI-MS Analyses using a Heated Extension Tube for the Direct Analysis of PlantsProtea Biosciences Group, Inc
02 Sep 2014
- Protea Biosciences Group, Inc
01 Sep 2014
Mass Spectrometry Imaging of Skin Wound Healing Biomarkers Using Laser Ablation Electrospray Ionization Mass Spectrometry (LAESI-MS)Protea Biosciences Group, Inc
29 Aug 2014